Skip to content

EPRX

Eupraxia Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$8.58
+2.39%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
4.33x
Price / sales
Price / cash flow
-15.81x

Enterprise value

Enterprise value
$463.2M
EV / sales
EV / EBITDA
-9.28x
EV / EBIT
-8.11x
Market cap
$566.9M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026